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Introduction: Understanding participant demographic characteristics that inform the opti-
mal design of obesity randomized controlled trials (RCTs) have been examined in few
studies. The objective of this study was to investigate the association of individual par-
ticipant characteristics and dropout rates (DORs) in obesity RCTs by pooling data from
several publicly available datasets for analyses. We comprehensively characterize DORs
and patterns in obesity RCTs at the individual study level, and describe how such rates and
patterns vary as a function of individual level characteristics.
Methods: We obtained and analyzed nine publicly available, obesity RCT datasets that
examined weight loss or weight gain prevention as a primary or secondary endpoint. Four
risk factors for dropout were examined by Cox proportional hazards including sex, age,
baseline BMI, and race/ethnicity.The individual study data were pooled in the final analyses
with a random effect for study, and HR and 95% CIs were computed.
Results: Results of the multivariate analysis indicated that the risk of dropout was signif-
icantly higher for females compared to males (HR=1.24, 95% CI=1.05, 1.46). Hispanics
and Non-Hispanic blacks had a significantly higher dropout rate compared to non-Hispanic
whites (HR=1.62, 95% CI=1.37, 1.91; HR=1.22, 95% CI=1.11, 1.35, respectively).There
was a significantly increased risk of dropout associated with advancing age (HR=1.02,
95% CI=1.01, 1.02) and increasing BMI (HR=1.03, 95% CI=1.03, 1.04).
Conclusion/Significance: As more studies may focus on special populations, researchers
designing obesity RCTs may wish to oversample in certain demographic groups if attempt-
ing to match comparison groups based on generalized estimates of expected DORs, or
otherwise adjust a priori power estimates. Understanding true reasons for dropout may
require additional methods of data gathering not generally employed in obesity RCTs, e.g.,
time on treatment.
Keywords: obesity, pooled analysis, randomized trials, dropout, participant characteristics
INTRODUCTION
Dropout is a major problem in studies of weight loss interventions
(1). Identification of predictors of dropout could be important to
enhance recruitment in vulnerable groups, as well as to develop
strategies to prevent dropout among those at high risk. Previous
investigations in single studies have reported baseline factors that
are associated with dropout including sex, age, marital status and
race, e.g., Ref. (2), or the presence of baseline comorbidities such
as Type 2 diabetes (3). Psychological predictors of dropout such
as motivation and stages of change have also been investigated
as factors, with little evidence of reliable predictive value across
multiple studies for many of the variables proposed (4). The pur-
pose of this investigation is to conduct a pooled meta-analysis to
identify baseline factors that are related to study retention among
a large cohort of subjects with racial/ethnic, age, sex, and body
weight heterogeneity.
MATERIALS AND METHODS
STUDY SAMPLES
For this investigation, individual level participant data from the
selected studies were obtained from the Biologic Specimen and
Data Repository Information Coordinating Center (BioLINCC),
for the National Heart, Lung, and Blood Institute (5) and from
the National Institute for Digestive and Diseases of the Kidney
(NIDDK) Central Data Repository (https://www.niddkrepository.
org). Searches were performed for studies meeting the inclusion
criteria defined as: the interventions were dietary and/or physical
activity interventions in free living people of any age, an outcome
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of interest was body weight, and basic demographic information
such as age, gender, and race were available in most records. Ten
were selected for inclusion (6–16). The investigation was approved
for secondary data analysis by the Institutional Review Board at
the University of Alabama at Birmingham.
DATA DEFINITIONS AND RECODING
The raw, de-identified datasets obtained were standardized for
consistency in coding prior to pooling. Variable codes were
assigned as follows: sex (0=male, 1= female); race (0=White,
Non-minority or non-Black, 1=Black, 2=Asian, 3=Hispanic,
4= other); age (continuous coded in years); body mass index
(BMI – continuous); dropout (0=No, 1=Yes for any time before
the protocol was completed), follow-up time (months). Treatment
groups were coded as nominal variables within each study. The
individual study frequency data were examined and compared to
study publications for accuracy (6–16).
STATISTICAL ANALYSIS
Descriptive statistics including means and standard deviations
(SD) for continuous data and frequency counts for categorical
predictors were generated by study as well as for the overall analy-
ses. The Cox model was used to estimate hazard ratios (HR) for
risk of dropout within each study. Proportionality assumptions
were assessed within each study by including a predictor term
in the model for the interaction of the predictors with time. If
a time-dependent covariate was significant, this could indicate a
violation of the proportionality assumption for that specific pre-
dictor. A Martingale residual analysis was used to examine whether
the functional form of the linear predictors was appropriate or
whether a quadratic term would improve model fit (17, 18).
For the combined analysis, the participant-level raw data were
pooled from the multiple studies. Two types of pooled analyses
were performed. The preliminary analyses combined the study-
specific HR and standard errors using the SAS METAANAL macro
(18) to produce the DerSimonian-Laird (19) estimator for ran-
dom effects. Plots of the study specific estimates as well as the
overall random effects model were visually inspected for hetero-
geneity among the studies for estimates of BMI, age, sex, and
race/ethnicity. Due to the significant heterogeneity detected on the
random effects models for univariate predictors, the final pooled
model using a combined dataset was run with PHREG® (SAS Ver.
9.2, Cary, NC, USA) using study as a random effect. Further mul-
tivariate Cox models were analyzed to include categorical terms
for BMI (<35, 35–39.9, ≥40) and age (<25, 25–64.9, ≥65) while
controlling for sex and race/ethnicity.
RESULTS
Table 1 summarizes the studies included in the meta-analysis
including a brief description, the endpoint for determining cen-
soring for dropout and the dropout proportion. The descriptive
characteristics for the covariates included in this investigation are
shown in Table 2. The results of the pooled analyses are in Table 3
(using age and BMI as continuous variables) and in Table 4 (using
age and BMI as categorical variables).
The results of univariate models including single factors in the
model for each study are shown in Tables 5–8. The testing of
residuals for age and BMI in each study did not show a significant
departure from expected simulations. In the Dietary Intervention
Study in Children (DISC) study, there was some indication of a
poor fit for a linear model for age, although this study involved
children aged 8–10 years old. The proportionality assumptions
for the interaction terms of gender by time, race by time, BMI
by time, and age by time were tested within each study. The
results showed a statistically significant interaction for gender by
time in the Dietary Approaches to Stop Hypertension (DASH)
study and TOHP1 study, and race by time in the Diabetes Pre-
vention Program (DPP) study. No other interaction terms were
significant.
POOLED ANALYSES
The combined cohort for pooled analyses consisted of 75,764 sub-
jects and the overall dropout percentage was 5.2% (n= 3821). The
distribution by gender was 53,938 females (71.2%) and 21,826
males (28.8%). The majority were non-Hispanic white (81.9%),
followed by non-Hispanic black (11.4%), Asian (3.2%), and His-
panic (1.9%). The mean age was 56.4 years (SD 11.1) and mean
baseline BMI was 28.9 (SD= 5.45).
Results of the multivariate analysis (Table 3) indicate that
the risk of dropout was significantly higher for females com-
pared to males (HR= 1.24, 95% CI 1.0, 1.46). Non-Hispanic
blacks had a significantly higher dropout rate compared to non-
Hispanic whites (HR= 1.22, 95% CI 1.11, 1.35) and Hispanics
were also significantly higher compared to non-Hispanic whites
(HR= 1.62, 95% CI 1.37, 1.91). There was a statistically significant
increased risk of dropout associated with advancing age (Hazard
Ratio= 1.01) and increasing BMI (HR= 1.03). The Wald test for
the random effect of study was significant (p< 0.001). Using age as
a categorical variable showed an increased risk of dropout for sub-
jects aged 65 years and over compared to those aged 25–64 years
(HR= 1.37; 95% CI= 1.26–1.49). Also individuals who were cate-
gorized as obese class II and obese class III (20) were more likely to
dropout compared to those who were categorized as overweight or
obese class I (HR= 1.40 and 1.69, respectively; Table 4). Figure 1
below shows the combined, overall dropout survival probability
using Cox proportional hazards projections. Figures 2–5 show
individual study hazard ratios of risk for drop out using BMI, age,
gender or race as predictors, respectively.
SENSITIVITY ANALYSIS
Because there were some inter-study definitions that were not
consistent for race [e.g., the DASH study coded race only as minor-
ity vs. non-minority and the Lipids Research Clinics (LRC) and
PREMIER studies coded race as Black vs. Non-Black], a sensi-
tivity analysis was conducted excluding these studies. An analysis
excluding the LRC and PREMIER studies did not show any appre-
ciable difference in the results from the random effects Cox model.
A second analysis excluding only the DASH study did not show
any significant differences from the combined model (data not
shown). Because our analysis included one study of children, who
may have differing factors that determine study retention, we
performed an additional sensitivity analysis excluding the DISC
study. There were no meaningful differences in the results or
interpretation following exclusion of the DISC data.
Frontiers in Nutrition | Nutrition Methodology December 2014 | Volume 1 | Article 25 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kaiser et al. Characteristics of dropouts in obesity RCTs
Table 1 | Endpoint determination and reference used for included studies.
Study title Study description Dropout determination Dropout
n (%)
Published
missingness n (%)
Activity Counseling
Trial (ACT) (11)
The ACT was a multicenter, randomized, controlled
trial to evaluate the effects of two primary care
based activity counseling regimens on physical
activity and cardiorespiratory fitness after
24 months when compared with a standard.
Subjects who did not complete
assessment at 2 years
81 (9.3) 75 (8.6) had no
assessment at
24 months
Dietary Approaches
to stop hypertension
(DASH) (10)
The DASH trial was a multicenter, randomized
feeding study that tested the effects of dietary
patterns on blood pressure. The intervention phase
was an 8-week period in which the subjects
followed their assigned diets.
Subjects who did not complete the
assessment at 8 weeks
17 (3.7) 13 (2.8) percentage
who did not
complete
intervention phase
Dietary Intervention
Study in Children
(DISC) (7)
The DISC study was a controlled clinical trial to
examine the efficacy and safety of long-term
dietary intervention for reduction of LDL-C in
pubescent children.
Subjects who did not attend the 3-year
lipid assessment visit
43 (6.5) 39 (5.9) number
with no outcome
data at 3 years
Diabetes Prevention
Program (DPP) (13)
A randomized trial was conducted to compare a
lifestyle intervention or metformin on the
development of diabetes.
The blinded treatment was terminated
early so dropout was assessed by an
algorithm provided by the investigator
(personal communication to author
Renee Desmond)
149 (4.1) 246 (7.6)
percentage who
had no follow-up
within last
5 months
Lipids Research
Clinics (LRC)
Coronary Primary
Prevention Trial (14)
The LRC CPPT was a multicenter, randomized,
double-blind clinical trial on the efficacy of
cholesterol lowering.
Subjects who did not complete the
minimum follow-up of 7 years
214 (5.7) Not reported
Multiple Risk Factor
Intervention Trial
(MRFIT) (12)
MRFIT was a randomized, primary prevention trial
to test whether lowering elevated serum
cholesterol and diastolic blood pressure and
ceasing cigarette smoking would reduce coronary
heart disease mortality.
Subjects who did not complete a
follow-up period of at least 6 years
1003 (7.8) Not reported
PREMIER (9) The objective of the randomized trial was to
determine the effect on blood pressure to two
multi-component behavioral interventions.
Subjects who did not complete the
primary outcome assessment at
6 months and did not complete the
18-month intervention
139 (17.2) 45 (5.5) did not
complete 6 months
follow-up although
intervention lasted
18 months
Trials of Hypertension
(TOHPI Lifestyle and
II) (6)
Three lifestyle change groups were compared with
unmasked non-intervention controls over
18 months to assess change in diastolic blood
pressure. Phase II TOHP was a multicenter
randomized controlled clinical trial with a 2×2
factorial design.
Subjects who did not complete an
18-month follow-up visit (Lifestyle
TOHP I) or subjects who did not
complete a 36-month follow-up visit
(TOPH II)
92 (6.3)
243 (10.2)
37 (4.2) of active
arms did not
complete follow-up
273 (11.5) did not
have weight at
36 months
Women’s Health
Initiative (WHI)
Dietary Modification
Trial (15)
The WHI dietary modification trial was designed to
examine the benefits and risk of a dietary pattern
low in fat on various outcomes in postmenopausal
women.
Subjects who were deceased or who
stopped follow-up before 7 years
2242 (4.6) 4071 (8.3)
withdrew, lost, or
deceased
DISCUSSION
Meta-analysis of individual level data has an advantage; in that, a
research question can be addressed that was not part of the original
research investigation. By obtaining the individual data, common
definitions can be used for coding variables and adjustments for
confounders may be performed. Obviously, the power for the
meta-analysis is greater than for the individual studies from which
the data are compiled. As such, the present analysis may be viewed
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Table 2 | Characteristics of included studies.
Factor ACT DASH DISC DPP LRC MRFIT PREMIER TOHP I TOHP II WHI
Gender
Male 479 (54.8) 234 (51.0) 362 (54.6) 362 (54.6) 3,774 (100.0) 12,866 (100.0) 310 (38.3) 1,037 (70.7) 1,566 (65.7) 0 (0.0)
Female 395 (45.2) 225 (49.0) 301 (45.4) 301 (45.4) 0 (0.0) 0 (0.0) 500 (61.7) 429 (29.3) 816 (34.3) 48,835 (100.0)
Race/ethnicity
Non-Hispanic White 597 (68.9) 156 (34.0) 574 (86.6) 2,117 (57.8) 3,601 (96.6) 11,559 (89.8) 531 (65.6) 1,182 (80.6) 1,888 (79.3) 39,762 (81.6)
Non-Hispanic Black 217 (25.0) 303 (66.0) 56 (8.5) 751 (20.5) 125 (3.4) 931 (7.3) 279 (34.4) 252 (17.2) 421 (17.7) 5,262 (10.8)
Asian 34 (3.9) 0 (0.0) 33 (5.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 73 (3.1) 1,105 (2.3)
Hispanic 0 (0.0) 0 (0.0) 0 (0.0) 609 (16.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1,845 (3.8)
Other 19 (2.2) 0 (0.0) 0 (0.0) 188 (5.1) 0 (0.0) 376 (2.9) 0 (0.0) 32 (2.2) 0 (0.0) 762 (1.6)
BMI
<18 4 (0.5) 0 (0.0) 459 (69.2) 0 (0.0) 6 (0.2) 21 (0.1) 0 (0.0) 5 (0.3) 0 (0.0) 86 (0.2)
18.5–24.9 210 (24.3) 114 (24.8) 202 (30.5) 0 (0.0) 1,215 (32.5) 2,649 (20.6) 39 (4.8) 354 (24.2) 24 (1.0) 12,551 (25.8)
25.0–29.9 303 (35.1) 179 (39.0) 2 (0.3) 1,199 (32.7) 2,215 (59.2) 7,125 (55.4) 242 (29.9) 694 (47.3) 1,014 (42.6) 17,425 (35.8)
≥30 346 (40.1) 166 (36.2) 0 (0.0) 2,466 (67.3) 305 (8.1) 3,071 (23.9) 529 (65.3) 413 (28.2) 1,344 (56.4) 18,591 (38.2)
*Obese class I 208 (59.2) 158 (95.2) 0 (0.0) 915 (37.1) 305 (100.0) 2659 (86.6) 241 (45.5) 372 (90.1) 1,048 (78.0) 11,216 (60.3)
*Obese class II 89 (23.6) 8 (4.8) 0 (0.0) 940 (38.1) 0 (0.0) 404 (13.2) 469 (32.0) 41 (9.9) 296 (22.0) 5,046 (27.1)
*Obese class III 49 (14.5) 0 (0.0) 0 (0.0) 611 (24.8) 0 (0.0) 8 (0.2) 119 (22.5) 0 (0.0) 0 (0.0) 2,329 (12.5)
Age
<29 0 (0.0) 49 (10.7) 663 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 11 (1.4) 0 (0.0) 0 (0.0) 0 (0.0)
30–49 434 (49.7) 283 (61.6) 0 (0.0) 1,811 (49.4) 2,257 (60.3) 8,670 (67.4) 426 (52.6) 1,162 (79.3) 1,899 (79.7) 2 (0.0)
50–69 403 (46.1) 118 (25.7) 0 (0.0) 1,854 (50.6) 1,487 (39.7) 4,196 (32.6) 359 (44.3) 304 (20.7) 483 (20.3) 40,711 (83.4)
>70 37 (4.2) 9 (2.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 14 (1.7) 0 (0.0) 0 (0.0) 8,122 (16.6)
BMI (mean, SD) 29.4 (6.0) 28.2 (3.8) 17.5 (2.4) 33.5 (95.7) 26.2 (2.6) 27.7 (3.5) 33.1 (5.7) 27.8 (3.7) 30.9 (3.1) 29.1 (5.7)
Age (mean, SD) 50.9 (10.0) 44.6 (10.7) 9.6 (0.7) 50.5 (9.3) 47.2 (6.5) 46.2 (6.0) 50.0 (9.1) 43.0 (6.5) 43.6 (6.2) 62.3 (6.9)
*n (%) within obese.
ACT, Activity CounselingTrial (11); DASH, Dietary Approaches to Stop Hypertension (10); DISC, Dietary Intervention Study in Children (7); DPP, Diabetes Prevention Program (13); LRC, Lipids Research Clinics Coronary
Primary Prevention Trial (14); MRFIT, Multiple Risk Factor Intervention Trial (12); PREMIER (9); TOHPI, Trials of Hypertension (Lifestyle I and II) (6) WHI, Women’s Health Initiative Dietary Modification Trial (15).
All values n (%).
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Table 3 | Results of pooled analysis of individual data for dropout risk
by baseline characteristics (n=75,764).
Factor Parameter
estimate
Standard
error
p HR (95% CI)
Gender
Male – 1
Female 0.21435 0.08517 0.0118 1.24 (1.05, 1.46)
Race
Non-Hispanic White – – – 1
Non-Hispanic Black 0.20127 0.04888 <0.0001 1.22 (1.11, 1.35)
Asian 0.21775 0.13263 0.1006 1.24 (0.96, 1.61)
Hispanic 0.48028 0.08424 <0.0001 1.62 (1.37, 1.91)
Other 0.24451 0.11038 0.0268 1.28 (1.03, 1.56)
Age (years) 0.01446 0.00237 <0.0001 1.02 (1.01, 1.02)
BMI (units) 0.03097 0.00303 <0.0001 1.03 (1.03, 1.04)
Table 4 | Results of pooled analysis of individual data for dropout risk
by baseline characteristics using categorical variables for age and BMI
(n=75,764).
Factor Parameter
estimate
Standard
error
P HR (95% CI)
Gender
Male – 1
Female 0.19961 0.08539 0.0194 1.22 (1.03, 1.44)
Race
Non-Hispanic White – – – 1
Non-Hispanic Black 0.22306 0.04874 <0.0001 1.25 (1.14, 1.38)
Asian 0.16679 0.13237 0.2077 1.18 (0.91, 1.53)
Hispanic 0.50321 0.08426 <0.0001 1.65 (1.40, 1.95)
Other 0.24367 0.11039 0.0273 1.28 (1.03, 1.58)
Age (years)
<25 years 1.19314 0.6954 0.0862 3.30 (0.84, 12.86)
25–64 years – – – –
≥65 years 0.31667 0.04184 <0.0001 1.37 (1.26, 1.49)
BMI (units)
<35 Class I or less – – – –
35–40 Class II 0.33444 0.05248 <0.0001 1.39 (1.26, 1.55)
>40 Class III 0.52731 0.07047 <0.0001 1.69 (1.48, 1.95)
as presenting very good estimates of the demographic and baseline
characteristics that may be associated with increased dropout rates
(DORs) in weight loss randomized controlled trials (RCTs).
Some disadvantages of performing a meta-analysis of this type
are that the results may not reflect all populations and the meta-
analysis itself may be subject to bias because some studies may be
excluded due to unavailability of raw data. If internal errors or
inconsistency are detected in the analysis, these issues may not be
able to be resolved, especially if the data are for public use and
tracing back to individual records is not possible. An examination
of the survival in study of a small single trial (N = 91 at base-
line) described the distribution of attrition to be exponential, with
Table 5 | Summary of effect estimates for Body Mass Index (BMI) by
study and estimates of effects in meta-analyses of dropout.
Study Parameter
estimate
Standard
error
Weight in fixed
effects model
Weight in random
effects model
ACT 0.07021 0.01676 0.02754 0.11135
LRC −0.01250 0.02669 0.01086 0.05682
DASH −0.04058 0.06338 0.00193 0.01196
DISC 0.16774 0.05975 0.00217 0.01339
DPP −0.01343 0.00467 0.03471 0.12785
MRFIT 0.02471 0.01028 0.07321 0.18225
PREMIER 0.02035 0.01529 0.03309 0.12439
TOHP I 0.01138 0.03193 0.00759 0.04213
TOHP II 0.00347 0.02925 0.00904 0.04887
WHI 0.02966 0.00311 0.79987 0.28076
Summary parameter estimate 0.0289 (SE=0.0071) p=<0.00001.
Q statistic for heterogeneity with 9 degrees of freedom=16.66, p=0.0543.
Table 6 | Summary of effect estimates for age by study and estimates
of effects in meta-analyses of dropout.
Study Parameter
estimate
Standard
error
Weight in fixed
effects model
Weight in random
effects model
ACT −0.01220 0.01223 0.03788 0.11078
LRC 0.01437 0.01063 0.05015 0.11780
DASH −0.01362 0.02348 0.01028 0.06695
DISC 0.18181 0.25408 0.00009 0.00105
DPP −0.02086 0.00964 0.06098 0.12205
MRFIT 0.00043 0.00608 0.15329 0.13568
PREMIER −0.01004 0.01002 0.05644 0.12043
TOHP I −0.02998 0.01887 0.01591 0.08289
TOHP II −0.00820 0.01495 0.02535 0.09887
WHI 0.02844 0.00310 0.58964 0.14351
Summary parameter estimate −0.0033 (SE=0.0082), p=0.6897.
Q statistic for heterogeneity with 9 degrees of freedom=59.52, p<0.001.
an estimated location parameter of Θ= 162 days (meaning 37%
remain in the study, 95% CI= 114, 230 days) (21). This example
demonstrates a significantly reduced survival on study compared
to the large trials that we examined. This difference may be reflec-
tive of the differences in resources available between large and
small studies. Therefore, our results should be interpreted with
caution in terms of applicability to smaller studies. A further
limitation of analysis using these types of datasets is the lack of
standard ways of coding certain variables often of interest, e.g.,
marital status (how to analyze “married” vs. “marriage-like rela-
tionship”?) and the differing diagnostic criteria used to identify
some types of comorbidities. While progress is being made in some
arenas of research, more work in standardization remains (22).
Additionally, we focused our analysis on randomized trials of
weight loss interventions using traditional diet and/or exercise
interventions, which may have very different attrition character-
istics than those of observational trials, or of RCTs of weight loss
drugs or surgical interventions. Therefore, our results may not be
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Table 7 | Summary of effect estimates for female gender vs. male by
study and estimates of random effects in meta-analyses of dropout.
Study Parameter
estimate
Standard
error
Weight in fixed
effects model
Weight in random
effects model
ACT 0.52895 0.24405 0.13221 0.14837
LRC – –
DASH 0.18547 0.50574 0.03079 0.05190
DISC 0.41449 0.36164 0.06021 0.08859
DPP −0.27767 0.18049 0.21473 0.19932
MRFIT – –
PREMIER 0.41463 0.19094 0.21599 0.18994
TOHP I 0.35147 0.26206 0.11467 0.13658
TOHP II 0.18377 0.19628 0.20440 0.18529
WHI – –
Summary parameter estimate 0.23303 (SE=0.1251), p=0.0657.
Q statistic for heterogeneity with 6 degrees of freedom=10.77, p= 0.0955.
Table 8 | Summary of effect estimates for black race vs. white by study
and estimates of random effects in meta-analyses of dropout.
Study Parameter
estimate
Standard
error
Weight in fixed
effects model
Weight in random
effects model
ACT 0.04334 0.26282 0.03518 0.06413
LRC −0.34757 0.45305 0.01184 0.02352
DASH 0.18448 0.55379 0.00792 0.01598
DISC 0.16821 0.53303 0.00855 0.01721
DPP 0.39616 0.18966 0.06756 0.11048
MRFIT 0.02200 0.13792 0.12777 0.17541
PREMIER 0.07304 0.17836 0.07640 0.12152
TOHP I 0.02583 0.32479 0.02304 0.04387
TOHP II −0.31392 0.26873 0.03365 0.06167
WHI 0.29874 0.06302 0.60808 0.36619
Summary parameter estimate 0.1481 (SE= 0.0711), p=0.0373.
Q statistic for heterogeneity with 9 degrees of freedom 11.42 p=0.2477
generalizable to these types of analyses due to such reasons as self-
selection bias [e.g., as discussed in Ref. (23) who reported higher
DORs in younger people] and differing amounts of weight lost that
can be observed in drug or surgery trials [e.g., as reported in Ref.
(24) who reported younger patients and those with lower BMI at
greater risk for dropout of a treatment program]. Weight loss drug
trials may have different factors such as side effects, or dissatisfac-
tion with being assigned to the placebo group, causing different
retention challenges. Our analysis did not include datasets from
these types of trials but hopefully in the future, such data will be
made publicly available.
With the presently increasing mean age of the US popula-
tion, there may be interest in testing weight loss interventions
in older samples and researchers should examine and plan for
ways to increase study retention in older participants. Further, for
studies that will include persons in the obese class II (BMI= 35–
39.9) and III (BMI> 40) categories, non-traditional interventions
and retention strategies may need to be employed to increase
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FIGURE 1 | Study survival probability (by not dropping out of the
study) including all subjects from pooled analyses (N =75,764).
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FIGURE 2 | Hazard ratios of body mass index (BMI) on dropout by
study.
our understanding of the effectiveness of weight loss interven-
tions similar to those we examined. The finding among these
datasets that being female was associated with higher DORs can-
not be explained by the data provided in the datasets used.
Researchers may wish to engage in the practice of performing
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FIGURE 3 | Hazard ratios of increased age and dropout by study.
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FIGURE 4 | Hazard ratios of female gender and dropout by study.
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FIGURE 5 | Hazard ratios of non-white race and dropout by study.
exit interviews in order to understand the true reasons partici-
pants dropped out of the study. Similarly, since there is increas-
ing interest in understanding the racial disparities of obesity
in the US, researchers would benefit from designing ways to
improve retention and gather regular feedback before a partici-
pant drops out of a study so that alternatives can be collaboratively
explored.
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